Safety and Efficacy of NPI-001 Tablets for RP Associated With Usher Syndrome

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
This study will examine the safety and efficacy of NPI-001 Tablets as compared to placebo for 24 months in subjects with vision loss due to RP associated with Usher syndrome.
Epistemonikos ID: 356e1ceb5959a66b15c77a4d17bf4a6362c30082
First added on: May 07, 2024